LY2228820 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

LY2228820 is a novel and potent p38MAPK inhibitor with potent antiinflammatory activity. LY2228820 significantly inhibited phosphorylation of MAPKAPK2 and/or HSP27, down stream targets of p38MAPK, in both multiple myeloma (MM) cell lines and LT-BMSCs. LY2228820 is a potential candidate to improve MM patient outcome both by enhancing the effect of Bortezomib (B675700) and by reducing osteoskeletal events.

LY2228820 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

LY2228820 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Capot Chemical Co.,Ltd.	+86-（0）57185586718 +86-13336195806	sales@capot.com	China	29791	60
ATK CHEMICAL COMPANY LIMITED	+undefined-21-51877795	ivan@atkchemical.com	China	32951	60
Hubei xin bonus chemical co. LTD	86-13657291602	linda@hubeijusheng.com	CHINA	22963	58
BOC Sciences	+1-631-485-4226	inquiry@bocsci.com	United States	19553	58
career henan chemical co	+86-0371-86658258 +8613203830695	factory@coreychem.com	China	29811	58
TargetMol Chemicals Inc.	+1-781-999-5354 +1-00000000000	marketing@targetmol.com	United States	32080	58
Dideu Industries Group Limited	+86-29-89586680 +86-15129568250	1026@dideu.com	China	22883	58
Zhejiang J&C Biological Technology Co.,Limited	+1-2135480471 +1-2135480471	sales@sarms4muscle.com	China	10473	58
InvivoChem	+1-708-310-1919 +1-13798911105	sales@invivochem.cn	United States	6391	58
TargetMol Chemicals Inc.		support@targetmol.com	United States	38470	58

862507-23-1()Verwandte Suche:

---

• 5-(2-tert-butyl-4-(4-fluorophenyl)-1H-imidazol-5-yl)-3-neopentyl-3H-imidazo[4,5-b]pyridin-2-amine dimethanesulfonate
• 5-(2-(tert-butyl)-5-(4-fluorophenyl)-1H-imidazol-4-yl)-3-neopentyl-3H-imidazo[4,5-b]pyridin-2-amine dimethanesulfonate
• LY2228820;LY 2228820;LY-2228820
• 5-(2-tert-Butyl-5-(4-fluorophenyl)-1H-imidazol-4-yl)-3-neopentyl-3H-imidazo[4,5-b]pyridin-2-am
• LY2228820
• 5-[2-(1,1-DiMethylethyl)-5-(4-fluorophenyl)-1H-iMidazol-4-yl]-3-(2,2-diMethylpropyl)-3H-iMidazo[4,5-b]pyridin-2-aMine DiMethanesulfonate
• LY2228820(LY-2228820)
• LY2228820 2MsOH
• LY2228820 diMesylate
• 5-[2-(tert-Butyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl]-3-(2,2-dimethylpropyl)-3H-imidazo[4,5-b]pyridin-2-amine methanesulfonate
• LY2228820 (Ralimetinib) dimesylate
• LY2228820 (mesylate)
• Ralimetinib Mesylate
• RALIMETINIB DIMESYLATE (LY2228820 DIMESYLATE)
• Ralimetinib 2MsOH(LY2228820)
• CS-371
• LY2228820 (Ralimetinib)
• RALIMETINIB DIMESYLATE; LY2228820 DIMESYLATE; LY2228820 2MSOH; LY 2228820; LY-2228820
• Ralimetinib 2MsOH
• LY2228820 USP/EP/BP
• Ralimetinib dimysylate (LY2228820 dimysylate)
• Ralimetinib mesylate LY2228820 LY-2228820
• 862507-23-1
• C24H29FN62CH4O3S
• C25H33FN6O3S
• C26H37FN6O6S2
• Inhibitors
• Aromatics
• Heterocycles
• Intermediates & Fine Chemicals
• Pharmaceuticals
• Protein Kinase Inhibitors and Activators
• MAPK